Brief: Cyclerion Therapeutics And Korsana Biosciences Announce Merger Agreement
April 1 (Reuters) - Cyclerion Therapeutics Inc CYCN.O: CYCLERION THERAPEUTICS AND KORSANA BIOSCIENCES ANNOUNCE MERGER AGREEMENT CO AND KORSANA ANNOUNCE DEFINITIVE ALL-STOCK MERGER AGREEMENT KORSANA SECURES PRIVATE INVESTMENT COMMITMENTS FOR $380 MILLION GROSS PROCEEDS COMBINED COMPANY TO BE LED BY JONATHAN VIOLIN, CURRENT CEO OF KORSANA Further company coverage: CYCN.O ((Reuters.Briefs@thomsonreuters.com;))